Lonza Group AG | 688.0000 / +1.07% |
Date/Time | 01/25 / 21:05 |
Chg. / Chg.(%) | 7.2500 / +1.07% |
Bid | - |
Ask | - |
Open | 682.5200 |
Previous Close | 680.7500 |
High | 688.0000 |
Low | 678.7800 |
Volume [USD] | 143,217.6440 |
Volume [Units] | 265 |
Price fixings | 12 |
ISIN | CH0013841017 |
Security | LZAGF |
Exchange | Nasdaq Other OTC |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
SIX Swiss Ex.. | 607.40 | ![]() |
246,639 |
London Inter.. | 607.40 | ![]() |
17,906 |
Nasdaq Other.. | 688.0000 | ![]() |
265 |
Lang & Schwa.. | 561.000 | ![]() |
|
Mexico | 13,537.55 | ![]() |
210 |
TradeGate | 294.000 | 298 | |
Frankfurt | 293.9000 | 63 | |
Düsseldorf | 291.20 | 0 | |
München | 291.30 | 0 | |
Berlin | 296.90 | 0 | |
Hamburg | 291.30 | 0 | |
gettex | 296.100 | ||
Singapore | 79.97 | 500 | |
EUREX | Options |
News
- Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
01/08/2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
12/23/2020 / 14:00 - GlobeNewswire - Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal Vaccine Candidate for COVID-19
11/10/2020 / 07:00 - GlobeNewswire - Institutional Investor Research Publishes 2020 Europe Executive Team Rankings
09/04/2020 / 07:00 - GlobeNewswire